Relationship between preexisting anti-varicella-zoster virus (VZV) antibody and clinical VZV reactivation in hematopoietic stem cell transplantation recipients
- PMID: 17035500
- PMCID: PMC1698415
- DOI: 10.1128/JCM.01312-06
Relationship between preexisting anti-varicella-zoster virus (VZV) antibody and clinical VZV reactivation in hematopoietic stem cell transplantation recipients
Abstract
Reactivation of latent varicella-zoster virus (VZV), presenting as localized zoster or as disseminated infection, is a common and potentially serious complication in hematopoietic stem cell transplantation (HSCT) recipients. We retrospectively studied anti-VZV immunoglobulin G titers by the immune adherence hemagglutination method after HSCT and also studied VZV DNA by real-time PCR during clinical VZV reactivation using cryopreserved serum samples. No significant difference was found between anti-VZV titers in 13 patients with VZV infection (localized zoster in 11 patients and disseminated zoster in 2 patients) and in 13 subjects without VZV infection at each time point after HSCT. Preexisting anti-VZV titers of disseminated zoster cases tended to be lower than those of localized zoster cases (P=0.10). Serum VZV DNA copy numbers at the onset of disseminated zoster cases tended to be higher than those of localized zoster cases (P=0.09). A strong inverse correlation was found between preexisting anti-VZV titer and serum VZV DNA at onset (r=-0.90, P=0.006). In HSCT recipients, preexisting antibody does not prevent the development of VZV reactivation but may contribute to decreased viral load at onset, resulting in a mild clinical course.
Figures

Similar articles
-
Allotype analysis to distinguish the origin of varicella-zoster virus immunoglobulin G after allogeneic stem cell transplantation.Biol Blood Marrow Transplant. 2013 Jul;19(7):1013-20. doi: 10.1016/j.bbmt.2013.04.007. Epub 2013 Apr 10. Biol Blood Marrow Transplant. 2013. PMID: 23583826
-
Persistence and antiviral resistance of varicella zoster virus in hematological patients.Clin Infect Dis. 2013 Feb;56(3):335-43. doi: 10.1093/cid/cis879. Epub 2012 Oct 16. Clin Infect Dis. 2013. PMID: 23074321
-
Serology indicates cytomegalovirus infection is associated with varicella-zoster virus reactivation.J Med Virol. 2014 May;86(5):812-9. doi: 10.1002/jmv.23749. Epub 2013 Sep 13. J Med Virol. 2014. PMID: 24037981
-
Disseminated varicella zoster virus infection in adult renal transplant recipients: outcome and risk factors.Transplant Proc. 2012 Nov;44(9):2814-7. doi: 10.1016/j.transproceed.2012.09.090. Transplant Proc. 2012. PMID: 23146530 Review.
-
Varicella zoster virus meningoencephalitis after allogeneic hematopoietic stem cell transplantation.Transpl Infect Dis. 2012 Aug;14(4):E7-12. doi: 10.1111/j.1399-3062.2012.00720.x. Epub 2012 Feb 20. Transpl Infect Dis. 2012. PMID: 22340704 Review.
Cited by
-
Two Waves of Specific B Cell Memory Immunoreconstruction Observed in Anti-HHV1-3 IgG Kinetics after Hematopoietic Stem Cell Transplantation.Biomedicines. 2024 Mar 3;12(3):566. doi: 10.3390/biomedicines12030566. Biomedicines. 2024. PMID: 38540179 Free PMC article.
-
Oncolytic varicella-zoster virus engineered with ORF8 deletion and armed with drug-controllable interleukin-12.J Immunother Cancer. 2024 Mar 25;12(3):e008307. doi: 10.1136/jitc-2023-008307. J Immunother Cancer. 2024. PMID: 38527762 Free PMC article.
-
Advances in the understanding of the pathogenesis and epidemiology of herpes zoster.J Clin Virol. 2010 May;48 Suppl 1(Suppl 1):S2-7. doi: 10.1016/S1386-6532(10)70002-0. J Clin Virol. 2010. PMID: 20510263 Free PMC article. Review.
-
Risks for infection in patients with asthma (or other atopic conditions): is asthma more than a chronic airway disease?J Allergy Clin Immunol. 2014 Aug;134(2):247-57; quiz 258-9. doi: 10.1016/j.jaci.2014.04.024. J Allergy Clin Immunol. 2014. PMID: 25087224 Free PMC article. Review.
-
Varicella-zoster virus-specific antibody responses in 50-59-year-old recipients of zoster vaccine.J Infect Dis. 2013 Nov 1;208(9):1386-90. doi: 10.1093/infdis/jit342. Epub 2013 Aug 1. J Infect Dis. 2013. PMID: 23908486 Free PMC article. Clinical Trial.
References
-
- Arvin, A. M. 2000. Varicella-zoster virus: pathogenesis, immunity, and clinical management in hematopoietic cell transplant recipients. Biol. Blood Marrow Transplant. 6:219-230. - PubMed
-
- Arvin, A. M. 2001. Varicella-zoster virus, p. 2731-2767. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 4th ed. Lippincott-Raven Publishers, Philadelphia, Pa.
-
- Centers for Disease Control and Prevention. 2004. CDC guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Morbid. Mortal. Wkly. Rep. 49:RR-10. - PubMed
-
- Han, C. S., W. Miller, R. Haake, and D. Weisdorf. 1994. Varicella-zoster infection after bone marrow transplantation: incidence, risk factors and complications. Bone Marrow Transplant. 13:277-283. - PubMed
-
- Kalter, Z. G., S. Steinberg, and A. A. Gershon. 1997. Immune adherence hemagglutination: further observations on demonstration of antibody to varicella-zoster virus. J. Infect. Dis. 135:1010-1013. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical